comparemela.com

Latest Breaking News On - Proposed merger - Page 18 : comparemela.com

VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Merger with Notable expected to close in late September or October, subject to VBL’s S-4 registration statement being declared effective and shareholder approval $24.3 million in cash and cash equivalents as of June 30, 2023 MODI’IN, Israel and NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced financial results for the second quarter ended June 30, 2023, and provided a corporate update. “We continue to make good progress towards the closing of o

Stratasys Releases Second Quarter 2023 Financial Results

The Agencies Release Consolidated Merger Guidelines: Insights From The Latest Signal For Expanded Merger Enforcement - Antitrust, EU Competition

On July 19, 2023, the Federal Trade Commission (FTC) and the Antitrust Division of the Department of Justice (DOJ) (collectively, the "Agencies") issued a draft update of the Merger Guidelines.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.